NICE turns down kidney cancer drugs

14th August 2017 Uncategorised 0

It is looking unlikely that patients in England and Wales with advanced renal cell carcinoma will be getting routine NHS access to Eisai’s Kisplyx or Eusa Pharma’s Fotivda, after cost regulators issued draft guidelines turning down their use.

More: NICE turns down kidney cancer drugs
Source: News